Blood Management Program in the Post - Operative Period.

Excessive Amount of Blood / Fluid Transfusion Clinical Trial

Official title:

Blood Management Program: Appropriateness of Transfusion Therapy in the Post - Operative Period.

Clinical Trial Details — Status: Unknown status

Administrative data

• NCT number: NCT02149069
• Other study ID #: BMP - TRASFU1
• Status: Unknown status
• Phase: N/A
• First received: May 26, 2014
• Last updated: July 31, 2015
• Start date: November 2014
• Est. completion date: January 2016

Study information

• Verified date: June 2015
• Source: Arcispedale Santa Maria Nuova-IRCCS
• Contact: Berni Pamela, Doctor
• Phone: 0039-0522-295601
• Email: pamela.berni[@]asmn.re.it
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A care path in the field of transfusion medicine was creates at ASMN - IRCCS addressed to patients undergoing complex surgical procedures.

Description:

This pathway is called Blood Management Program (BMP).

The implementation of this process should improve transfusion therapy in the peri-operative period in order to:

• correct the transfusional approach to surgical patients

• optimize the management of transfusional resources (red blood cells, plasma, platelets)

• optimize the management of plasma derivatives, drugs and techniques designed to limit the use of homologous blood

Recruitment information / eligibility

• Status: Unknown status
• Enrollment: 200
• Est. completion date: January 2016
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

-All patients undergoing complex surgical procedures

Exclusion Criteria:

Related Conditions & MeSH terms

• Excessive Amount of Blood / Fluid Transfusion

Locations

Country	Name	City	State
Italy	IRCCS-Arcispedale Santa Maria Nuova	Reggio Emilia	Emilia Romagna

Sponsors (1)

Lead Sponsor	Collaborator
Arcispedale Santa Maria Nuova-IRCCS

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluation of therapeutic appropriateness for Red Cells - Plasma - Platelets transfusion: comparison between prospective vs. retrospective data in ASMN ,Reggio Emilia (Italy)		24 months